Application practice of drug clinical comprehensive evaluation thinking in management of temporary drug purchase in hospital

YANG Xue; LI Chen; CAI Yongqing; XIAN Qiuwan; XING Haiyan

doi:10.6039/j.issn.1001-0408.2023.10.04

您当前的位置：

首页 >

文章列表页 >

Application practice of drug clinical comprehensive evaluation thinking in management of temporary drug purchase in hospital

更新时间：2025-09-27

- Application practice of drug clinical comprehensive evaluation thinking in management of temporary drug purchase in hospital
- ZHONGGUO YAOFANG Vol. 34, Issue 10, Pages: 1172-1176(2023)
- 作者机构：
  
  1.陆军特色医学中心药剂科，重庆　400042
  2.陆军特色医学中心医研部医疗办公室，重庆　400042
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2023.10.04
  CLC： R95
- Received：09 November 2022，
  
  Revised：2023-04-19，
  
  Accepted：20 April 2023，
  
  Published：30 May 2023
- 稿件说明：
移动端阅览
杨雪,李晨,蔡永青,等.药品临床综合评价思维在医院药品临时采购管理中的应用实践[J].中国药房,2023,34(10):1172-1176.

YANG Xue,LI Chen,CAI Yongqing,et al.Application practice of drug clinical comprehensive evaluation thinking in management of temporary drug purchase in hospital[J].ZHONGGUO YAOFANG,2023,34(10):1172-1176.
杨雪,李晨,蔡永青,等.药品临床综合评价思维在医院药品临时采购管理中的应用实践[J].中国药房,2023,34(10):1172-1176. DOI： 10.6039/j.issn.1001-0408.2023.10.04.

YANG Xue,LI Chen,CAI Yongqing,et al.Application practice of drug clinical comprehensive evaluation thinking in management of temporary drug purchase in hospital[J].ZHONGGUO YAOFANG,2023,34(10):1172-1176. DOI： 10.6039/j.issn.1001-0408.2023.10.04.

摘要

目的

探索构建药品临时采购的科学化管理新模式，为医疗机构提升合理用药水平提供参考。

方法

我院以临床诊疗需求和患者用药安全为导向，通过优化审评流程、创建审评团队、基于药品临床综合评价制定事前审核及事后跟踪评价标准，开展临时采购药品全程化管理实践，并通过临时采购申请数量、执行率、药品目录结构优化情况等指标评价实践效果。

结果

2021年1月我院开始实施药品临时采购科学化管理新模式，截至2022年12月，我院临床药师共审核药品临时采购申请111份，有效拦截不合理申请13份（11.71%），药品临时采购执行率整体下降了8.36%，提出药品目录结构优化建议5次；我院先后引进了卡瑞利珠单抗、索拉非尼、白消安等24种药品。管理模式优化后，药品临时采购申请次数由2019年的133次和2020年的138次，减少到2021年的66次和2022年的45次，降幅达一半以上。

结论

该模式有助于优化医疗机构药品目录，提升合理用药水平，保障患者用药安全，充分体现了临床药师在医疗机构药事管理与合理用药中的专业价值。

Abstract

OBJECTIVE

To explore the construction of a new scientific management model for temporary drug purchase，and to provide a reference for hospitals to improve the level of rational drug use.

METHODS

Guided by clinical diagnosis and treatment needs and patient medication safety， our hospital carried out the whole process management practice of temporarily purchased drugs by optimizing the review process， creating a review team， formulating pre-audit and post follow-up evaluation standards based on comprehensive drug evaluation， and evaluated the practice effect through the number of temporary purchase applications， implementation rate， drug structure optimization and other indicators.

RESULTS

Since January 2021， our hospital had implemented a new mode of temporary drug purchase management. By December 2022， clinical pharmacists had reviewed 111 temporary drug procurement applications， effectively intercepted 13 irrational drug use applications （11.71%）， reduced the overall implementation rate of temporary drug procurement by 8.36%，and proposed five batches of drug structure optimization suggestions； 24 drugs were successively introduced such as camrelizumab，sorafenib，busulfan. After optimizing the management mode，the number of temporary drug procurement applications decreased by more than half from 133 in 2019 and 138 in 2020 to 66 in 2021 and 45 in 2022.

CONCLUSIONS

The model is helpful to optimize the hospital drug catalog， strengthen rational drug use，ensure the safety of patients’ drug use， and fully reflects the professional value of clinical pharmacists in hospital pharmacy management and rational drug use.

关键词

Keywords

references

陈慧，苏广全，刘晓，等 . 中国医疗机构药品目录管理评价指南 [J ] . 中国药房， 2022 ， 33 （ 6 ）： 641 - 652 .

国家卫生健康委，教育部，财政部，等 . 关于印发加强医疗机构药事管理促进合理用药的意见的通知：国卫医发〔2020〕 2 号[EB/OL ] .（ 2020-02-26 ）[ 2022-11-01 ] . http：//www.nhc.gov.cn/yzygj/s7659/202002/ea3b96d1ac094c47-a1fc39cf00f3960e.shtml http://www.nhc.gov.cn/yzygj/s7659/202002/ea3b96d1ac094c47-a1fc39cf00f3960e.shtml .

赵志刚，董占军，刘建平 . 中国医疗机构药品评价与遴选快速指南 [J ] . 医药导报， 2020 ， 39 （ 11 ）： 1457 - 1465 .

国家卫生健康委办公厅 . 国家卫生健康委办公厅关于规范开展药品临床综合评价工作的通知：国卫办药政发〔2021〕 16 号[EB/OL ] .（ 2021-07-28 ）[ 2022-11-01 ] . http：//www.nhc.gov.cn/yaozs/s2908/202107/532e20800a47415-d84adf3797b0f4869.shtml http://www.nhc.gov.cn/yaozs/s2908/202107/532e20800a47415-d84adf3797b0f4869.shtml .

邓建华，吴海坤，李薇，等 . 北京协和医院基于SMART原则的泌尿外科专科腔镜规范化培训的经验总结 [J ] . 中国医学科学院学报， 2023 ， 45 （ 1 ）： 88 - 91 .

卫生部 . 抗菌药物临床应用管理办法：卫生部令第84号 [EB/OL ] .（ 2012-04-24 ）[ 2022-11-01 ] . http：//www.nhc.gov.cn/wjw/c100022/202201/8fcae32c3f1f467eb795ee816e23-87d6.shtml http://www.nhc.gov.cn/wjw/c100022/202201/8fcae32c3f1f467eb795ee816e23-87d6.shtml .

国家卫生健康委 . 国家卫生健康委关于印发抗肿瘤药物临床应用管理办法（试行）的通知：国卫医函〔2020〕 487 号[EB/OL ] .（ 2020-12-28 ）[ 2022-11-01 ] . http：//www.nhc.gov.cn/yzygj/s7659/202012/a7600740bed44d1db7015ca5-a1be2cc0.shtml http://www.nhc.gov.cn/yzygj/s7659/202012/a7600740bed44d1db7015ca5-a1be2cc0.shtml .

国家医疗保障局，国家卫生健康委 . 国家医疗保障局国家卫生健康委关于适应国家医保谈判常态化持续做好谈判药品落地工作的通知：医保函〔2021〕 182 号[EB/OL ] .（ 2021-09-10 ）[ 2022-11-01 ] . http：//www.nhsa.gov.cn/art/2021/9/10/art_104_6543.html http://www.nhsa.gov.cn/art/2021/9/10/art_104_6543.html .

国家卫生健康委，科学技术部，工业和信息化部，等 . 关于公布第一批罕见病目录的通知：国卫医发〔2018〕 10 号[EB/OL ] .（ 2018-06-08 ）[ 2022-11-01 ] . http：//www.nhc.gov.cn/yzygj/s7659/201806/393a9a37f39c4b458d6e830f40a4-bb99.shtml http://www.nhc.gov.cn/yzygj/s7659/201806/393a9a37f39c4b458d6e830f40a4-bb99.shtml .

北京协和医院罕见病多学科协作组，中国罕见病联盟 . 多准则决策分析应用于罕见病药品临床综合评价的专家共识：2022 [J ] . 协和医学杂志， 2022 ， 13 （ 2 ）： 235 - 254 .

Views

258

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Pharmaceutical care for toxic epidermal necrolysis in patients with deep vein thrombosis and acute renal insufficiency induced by warfarin

Multidimensional optimization strategies and practical effects of prescription pre-review system

Prospective cohort study on clinical pharmacist involvement in the management of opioid use after orthopedic surgery under the enhanced recovery after surgery model

One case report and literature review of severe cardiotoxicity by oxaliplatin combined with capecitabine

Pharmaceutical care in a patient with hemorrhagic transformation after cerebral infarction complicated with atrial fibrillation

Related Author

SHI Chao

SHU Dezhong

GAO Guangming

LIU Tianjiao

XU Na

LIANG Jing

SUN Xiangju

ZHU Zhanguo

Related Institution

Dept. of Pharmacy， Fuling Hospital Affiliated to Chongqing University

Dept. of Clinical Pharmacy， the Fourth Affiliated Hospital of Harbin Medical University

Dept.of Pharmacy， Baoding No.1 Central Hospital

Dept. of Pharmacy， Medical Supplies Center， Chinese PLA General Hospital

Dept. of Oncology， Qilu Hospital of Shandong University

Address：8th Floor, Sihuan Building, No. 129 Daping Main Street, Yuzhong District, Chongqing, China Postal code：400042
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰